This inventor holds 2 USPTO granted patents. Top assignee: Chiron Corporation. Active years: 1998.
Location History:
- Princeton, NJ (US) (1998)
- Oakland, CA (US) (1998)
Company Filing History:
Years Active: 1998
Title: Edward C O'Rourke: Innovator in Cancer Diagnostics
Introduction
Edward C O'Rourke is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of cancer diagnostics through his innovative work. With a total of 2 patents, O'Rourke has focused on developing methods that enhance the understanding and detection of cancer-related proteins.
Latest Patents
O'Rourke's latest patents include the Native Type II GAP and methods for purifying various GAPs. These patents describe the uses of GTPase activating proteins (GAPs) in cancer diagnosis. Specifically, they detail methods for obtaining and purifying native and recombinant Types I and II GAPs. Additionally, he has described GAP gene sequences that are particularly useful for detecting cancer cells expressing the ras oncogene protein p21. This is achieved by measuring the level of GAP gene expression or amplification.
Career Highlights
Edward C O'Rourke has had a distinguished career, primarily working with Chiron Corporation. His work has been pivotal in advancing cancer diagnostics, making significant strides in the understanding of GAPs and their implications in cancer research.
Collaborations
O'Rourke has collaborated with notable colleagues such as Francis P McCormick and Bonnee Rubinfeld. These collaborations have further enriched his research and contributions to the field.
Conclusion
In summary, Edward C O'Rourke is a prominent inventor whose work in cancer diagnostics has led to valuable patents and advancements in the understanding of GAPs. His contributions continue to impact the field significantly.